Prescription Drug Spending Estimates

Forecast Recompete Updated

Agency
Solicitation expected
Estimated value
$500,000 to $1,000,000
Set-aside
Not on record

Forecast facts

Incumbent contract
Previous solicitation
Prescription Drug Spending Estimates FY2024 Award Notice · RFQAPPNO240976 · Posted May 22, 2024
Anticipated award
Acquisition strategy
Follow-on to Existing Contract
NAICS code
541611 Administrative Management and General Management Consulting Services
Forecast number
270588
Points of contact

Forecast details come from CMS's procurement forecast. Agencies' dates and values are estimates.

About this forecast

The Centers for Medicare and Medicaid Services (CMS) is forecasting a recompete to purchase descriptive statistical data on the prescription drug industry, with an estimated solicitation release on February 2, 2027 and an estimated award on May 11, 2027. The data will support expenditure estimates for prescription drugs within the National Health Expenditure Accounts, and the National Health Statistics Group within the Office of the Actuary (OACT) is the requiring organization. The forecast lists the action type as sole source and the set-aside as to be determined.

The estimated award value range is $500,000 to $1,000,000, and the current fiscal year value range is $150,000 to under $500,000. The estimated period of performance starts May 17, 2027. Points of contact are Todd Caldis (todd.caldis@cms.hhs.gov, +14107861217, HHS.gov) and Elliott Sloan, Contracting Officer (elliott.sloan@cms.hhs.gov, +14107860320, CMS).

This forecast recompetes Contract 75FCMC24C0016, awarded to IQVIA Government Solutions Inc. on May 17, 2024 as a firm fixed-price definitive contract with no set-aside, valued at $508,006 in both obligated dollars and ceiling and running through May 16, 2027. The contract purchases national health accounts data to update the 2023-2026 National Health Expenditures Accounts retail prescription drug expenditures estimate and other CMS projects, with service contract inventory reporting $188,000 invoiced in FY2024 and $157,000 in FY2025.

Forecast text

The National Health Statistics Group (NHSG) within the Office of the Actuary (OACT) is seeking to purchase descriptive statistical data on the prescription drug industry. This data will support the development of expenditure estimates for prescription drugs as part of the National Health Expenditure Accounts.

On GovTribe

Work this forecast

  • Track it in your pipeline
  • Find teaming partners
  • Similar forecasts
  • Ask GovTribe AI about this forecast